Average Co-Inventor Count = 8.00
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Silver Creek Pharmaceuticals, Inc. (5 from 10 patents)
5 patents:
1. 12122819 - Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant
2. 11879002 - Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof
3. 11155593 - Method of inhibiting apoptosis or promoting cell survival by providing a bi-specific protein comprising insulin-like growth factor IGF-1 and Annexin A5
4. 10633425 - Method of protecting tissue from damage by administering a bi-specific therapeutic protein comprising insulin-like growth factor 1 (IGF-1) and Annexin A5
5. 10040840 - Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue